Morgens Waterfall Vintiadis & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,000
Closed -$3.69M 22
2024
Q4
$3.69M Buy
+40,000
New +$3.6M 2.82% 18
2022
Q1
Sell
-30,000
Closed -$2.18M 31
2021
Q4
$2.18M Sell
30,000
-20,300
-40% -$1.4M 1.17% 22
2021
Q3
$7.18M Buy
+50,300
New +$3.53M 3.7% 12
2017
Q4
Sell
-25,000
Closed -$2.03M 63
2017
Q3
$2.03M Buy
+25,000
New +$1.91M 1.7% 26
2016
Q2
Sell
-44,000
Closed -$4.04M 57
2016
Q1
$4.04M Sell
44,000
-22,800
-34% -$2.06M 2.8% 4
2015
Q4
$6.76M Hold
66,800
2.83% 5
2015
Q3
$6.56M Sell
66,800
-10,000
-13% -$1.11M 3.61% 4
2015
Q2
$8.99M Sell
76,800
-18,200
-19% -$1.99M 5.66% 1
2015
Q1
$9.32M Buy
95,000
+35,000
+58% +$3.55M 5.98% 2
2014
Q4
$5.66M Buy
60,000
+20,000
+50% +$2.07M 3.16% 10
2014
Q3
$4.26M Sell
40,000
-35,000
-47% -$3.43M 2.98% 13
2014
Q2
$6.22M Buy
+75,000
New +$5.84M 4.08% 10
2014
Q1
Sell
-110,000
Closed -$8.26M 45
2013
Q4
$8.26M Sell
110,000
-30,000
-21% -$2.09M 5.66% 4
2013
Q3
$8.8M Hold
140,000
6.46% 2
2013
Q2
$7.18M Buy
+140,000
New +$7.3M 5.47% 4

Other funds holding GILD

Morgens Waterfall Vintiadis & Co's GILD Position: Q1 2025 in Review

Morgens Waterfall Vintiadis & Co sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 40,000 shares — an estimated $3.69M sold.

Morgens Waterfall Vintiadis & Co first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $9.32M in Q1 2015. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Morgens Waterfall Vintiadis & Co reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 40,000 Gilead Sciences shares in Q1 2025, an estimated $3.69M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Morgens Waterfall Vintiadis & Co's Gilead Sciences position peaked at $9.32M in Q1 2015.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2025, filed 15 May 2025.